News Room

All Press Releases In The News Blogs
15 May 2017
Press Release
Minerva Provides Update on Phase 3 Design and Development Strategy for MIN-101 
Minerva Neurosciences (NASDAQ: NERV)
12 May 2017
Press Release
Patrick Amstutz Appointed as Chief Executive Officer 
Molecular Partners (S​wiss​: MOLN.SW)
11 May 2017
Press Release
Panel of Leading Pain Management Specialists Highlight Potential Role of Abuse-Deterrent Formulations of Opioids and Non-Narcotics to Help Curb Misuse and Abuse at Egalet Investor Day 
Egalet (NASDAQ:EGLT)
10 May 2017
Press Release
Egalet Reports First Quarter 2017 Financial Results 
Egalet (NASDAQ:EGLT)
09 May 2017
Press Release
Molecular Partners’ strategic partner Allergan completed patient recruitment in both abicipar pegol nAMD Phase 3 studies 
Molecular Partners (S​wiss​: MOLN.SW)
08 May 2017
Press Release
GenSight Biologics to Present Data on GS010 and GS030 at the Annual Meeting of ARVO 
Gensight (Euronext: SIGHT)
04 May 2017
Press Release
Minerva Neurosciences Reports First Quarter 2017 Financial Results and Business Updates 
Minerva Neurosciences (NASDAQ: NERV)
03 May 2017
Press Release
Spin-out Z Factor announces £7 million Series A funding to bring lung treatment to the clinic 
Z Factor - Centessa Therapeutics (NASDAQ:CNTA)
03 May 2017
Press Release
Acutus Medical® Receives FDA Clearance for AcQGuideTM Steerable Sheath 
Acutus Medical
03 May 2017
Press Release
GenSight Biologics Appoints Mohamed Genead as Chief Medical Officer 
Gensight (Euronext: SIGHT)
28 Apr 2017
Press Release
GenSight Biologics Announces the Filing of its 2016 Registration Document 
Gensight (Euronext: SIGHT)
27 Apr 2017
Press Release
Acutus Medical® Announces Completion of Enrollment for UNCOVER AF™ Study of AcQMap® in Persistent Atrial Fibrillation 
Acutus Medical
27 Apr 2017
Press Release
Versartis Reports First Quarter 2017 Financial Results 
Versartis (NASDAQ: VSAR)
27 Apr 2017
Press Release
GenSight Biologics to Present GS010 at the 4th Annual Retinal Cell & Gene Therapy Innovation Summit 
Gensight (Euronext: SIGHT)
27 Apr 2017
Press Release
Minerva Neurosciences to Report First Quarter 2017 Financial Results and Business Updates on May 4, 2017 
Minerva Neurosciences (NASDAQ: NERV)
26 Apr 2017
Press Release
Egalet to Report First Quarter 2017 Financial Results During Investor Day on May 10, 2017 in New York 
Egalet (NASDAQ:EGLT)
25 Apr 2017
Press Release
ObsEva SA Initiates Phase 3 Clinical Program for OBE2109 in Uterine Fibroids 
ObsEva (NASDAQ: OBSV)
25 Apr 2017
Press Release
Versartis Appoints Jay Stout, Ph.D., as Senior Vice President, Technical Operations 
Versartis (NASDAQ: VSAR)
20 Apr 2017
Press Release
GenSight Biologics to Present GS010 at the 2017 Annual Meeting of the American Academy of Neurology 
Gensight (Euronext: SIGHT)
18 Apr 2017
Press Release
Egalet Announces U.S. Food and Drug Administration Acceptance of File for Prior Approval Supplement for OXAYDO® (oxycodone HCl, USP) tablets C-II 10 mg and 15 mg Dosage Strengths 
Egalet (NASDAQ:EGLT)
12 Apr 2017
Press Release
Christian Zahnd appointed as Honorary Chairman of the Board of Directors as he decided not to stand for re-election as member of the Board of Directors at the Annual General Meeting 2017 
Molecular Partners (S​wiss​: MOLN.SW)
10 Apr 2017
Press Release
Egalet Corporation Announces Changes to Board of Directors 
Egalet (NASDAQ:EGLT)
03 Apr 2017
Press Release
Versartis Reports New Data on Long-Acting Somavaratan in Growth Hormone Deficiency at ENDO 2017 
Versartis (NASDAQ: VSAR)
03 Apr 2017
Press Release
Versartis Announces Three Year Somavaratan Data at ENDO 2017 Showing Safety and Efficacy in Line with Historical U.S. Daily rhGH Data in Pediatric GHD 
Versartis (NASDAQ: VSAR)
01 Apr 2017
In The News
Nature Biotech
Gadeta: extending the reach of CAR T cells 
31 Mar 2017
Press Release
Molecular Partners Publishes Audited Financial Results and Annual Report 2016 
Molecular Partners (S​wiss​: MOLN.SW)
29 Mar 2017
Press Release
Egalet Announces U.S. Food and Drug Administration Does Not Object to Egalet's Distribution of Materials and Communications to Healthcare Professionals Regarding Abuse-Deterrent Properties of ARYMO™ ER via Intranasal Route 
Egalet (NASDAQ:EGLT)
23 Mar 2017
Press Release
SuperX Awarded Cambridge Torchbearer Award at 2017 Business Weekly Annual Awards Dinner 
SuperX
21 Mar 2017
Press Release
Minerva Neurosciences Announces Recent Exercise of Warrants by Institutional Stockholders and Open Market Purchase of Common Stock by Chairman of Its Board of Directors 
Minerva Neurosciences (NASDAQ: NERV)
17 Mar 2017
Press Release
ObsEva to Present Pharmacology Results Demonstrating OBE022 Exerts a Synergistic Effect in Combination with Standard of Care in Animal Model for Preterm Labor 
ObsEva (NASDAQ: OBSV)
15 Mar 2017
Press Release
Versartis Appoints Tracy Woody as Chief Commercial Officer 
Versartis (NASDAQ: VSAR)
13 Mar 2017
Press Release
GenSight Biologics Reports Full Year 2016 Financial Results 
Gensight (Euronext: SIGHT)
13 Mar 2017
Press Release
Minerva Neurosciences Reports Fiscal 2016 Fourth Quarter and Year End Financial Results and Business Updates 
Minerva Neurosciences (NASDAQ: NERV)
09 Mar 2017
Press Release
Egalet Reports Fourth Quarter and Full Year 2016 Financial Results 
Egalet (NASDAQ:EGLT)
07 Mar 2017
Press Release
ObsEva Starts Phase 3 Clinical Program for Nolasiban in ART 
ObsEva (NASDAQ: OBSV)
06 Mar 2017
Press Release
Minerva Neurosciences to Report Fiscal 2016 Fourth Quarter and Year End Financial Results and Business Updates on March 13, 2017 
Minerva Neurosciences (NASDAQ: NERV)
02 Mar 2017
Press Release
Versartis Announces Data on Long-Acting Somavaratan for Growth Hormone Deficiency to be Featured in Late-Breaker Presentation at ENDO 2017 
Versartis (NASDAQ: VSAR)
01 Mar 2017
Press Release
Versartis to Present at Cowen & Co. Annual Healthcare Conference and Barclays Global Healthcare Conference 
Versartis (NASDAQ: VSAR)
21 Feb 2017
Press Release
GenSight Biologics Completes Enrollment of REVERSE Phase III Study of GS010 in the treatment of LHON 
Gensight (Euronext: SIGHT)
21 Feb 2017
Press Release
Minerva Neurosciences to Host R&D Day Focused on Unmet Needs and Emerging Treatment Strategies in Schizophrenia 
Minerva Neurosciences (NASDAQ: NERV)
16 Feb 2017
Press Release
Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc. 
Ariad - Acquired by Takeda (NASDAQ: ARIA)
09 Feb 2017
In The News
Newswire
XO1 Founding Management Team Re-Unite to Launch SuperX and Announce $11m Series A Funding With Medicxi and Johnson & Johnson Innovation-JJDC 
09 Feb 2017
Press Release
Molecular Partners reports preliminary unaudited key financials for 2016: Advancements across all therapeutic areas – Ongoing strong cash position 
Molecular Partners (S​wiss​: MOLN.SW)
05 Feb 2017
In The News
The Times
How to make our spinouts graduate into new Googles 
03 Feb 2017
Press Release
Cambridge Enterprise joins in £14m funding round for spin-out ApcinteX Limited 
ApcinteX - Centessa Therapeutics (NASDAQ:CNTA)
31 Jan 2017
Press Release
Versartis Promotes Joshua T. Brumm to Chief Operating Officer and Paul Westberg to Chief Business Officer 
Versartis (NASDAQ: VSAR)
31 Jan 2017
Press Release
GenSight Biologics receives FDA Orphan Drug Designation for GS030 in Retinitis Pigmentosa 
Gensight (Euronext: SIGHT)
30 Jan 2017
Press Release
Versartis' Long-Acting Somavaratan for Growth Hormone Deficiency to be Featured in Multiple Oral and Poster Presentations at ENDO 2017 
Versartis (NASDAQ: VSAR)
25 Jan 2017
Press Release
ObsEva SA Announces Pricing of Initial Public Offering 
ObsEva (NASDAQ: OBSV)
23 Jan 2017
In The News
Business Wire
Fierce MedicalDevices names Acutus Medical® as one of its “Fierce 15” Medical Device Companies of 2016 
20 Jan 2017
Press Release
Additional Data Analyses From Phase IIb Trial of MIN-101 in Schizophrenia Underscore Benefit in Multiple Measurements of Cognitive Function 
Minerva Neurosciences (NASDAQ: NERV)
18 Jan 2017
Press Release
Egalet Closes Second Tranche of $80 Million Secured Debt Financing 
Egalet (NASDAQ:EGLT)
09 Jan 2017
Press Release
Egalet Receives FDA Approval for ARYMO™ ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain 
Egalet (NASDAQ:EGLT)
04 Jan 2017
Press Release
Molecular Partners to Present at the 35th ANNUAL J.P. MORGAN Healthcare Conference 
Molecular Partners (S​wiss​: MOLN.SW)
20 Dec 2016
Press Release
GenSight Biologics reports sustained visual acuity gain at 78 weeks in its Phase I/II Study with GS010 for the treatment of Leber’s Hereditary Optic Neuropathy (LHON) 
Gensight (Euronext: SIGHT)
20 Dec 2016
Press Release
Minerva Neurosciences Names Michael Davidson, M.D. as Chief Medical Officer 
Minerva Neurosciences (NASDAQ: NERV)
16 Dec 2016
Press Release
Egalet Announces Positive Top-Line Results from an Intranasal Human Abuse Potential Study of Egalet-002 
Egalet (NASDAQ:EGLT)
05 Dec 2016
Press Release
Minerva Neurosciences' Clinical Data Featured at The American College of Neuropsychopharmacology Annual Meeting 
Minerva Neurosciences (NASDAQ: NERV)
07 Nov 2016
Press Release
Versartis Presents Safety, Efficacy and IGF-I Data for Somavaratan in Pediatric Growth Hormone Deficiency at the 2016 Congress of the GRS & IGF Society 
Versartis (NASDAQ: VSAR)
18 Oct 2016
Press Release
Fierce Biotech
Medicxi founds Parkinson’s startup, commits €9M 
29 Sep 2016
In The News
BioCentury Innovations
Emerging Company Profile: Composite T Cells 
08 Sep 2016
Press Release
GenSight Biologics receives approval to include teenage patients in RESCUE and REVERSE Phase III trials with GS010 in Leber’s Hereditary Optic Neuropathy 
Gensight (Euronext: SIGHT)
01 Sep 2016
Press Release
The European Medicines Agency (EMA), has granted orphan drug designation (ODD) to the Company’s product candidate GS030 for the treatment of retinitis pigmentosa 
Gensight (Euronext: SIGHT)
11 Aug 2016
Press Release
GenSight Biologics confirms the success of its IPO by exercising 88.9% of the over-allotment option 
Gensight (Euronext: SIGHT)
04 Aug 2016
Press Release
Egalet Announces FDA Advisory Committees Recommend Approval of Abuse-Deterrent ARYMO™ ER (Morphine Sulfate) and Reports Second Quarter 2016 Financial Results 
Egalet (NASDAQ:EGLT)
19 Jul 2016
Press Release
BVF Partners L.P., a US-based investor focused on biotechnology investments, acquired shares from pre-IPO venture capital shareholders 
Molecular Partners (S​wiss​: MOLN.SW)
12 Jul 2016
Press Release
French gene therapy firm GenSight raises 40 mln euros in IPO 
Gensight (Euronext: SIGHT)
08 Jun 2016
Press Release
GenSight Biologics announces additional promising results of its Phase I/II study with GS010 for the treatment of Leber’s Hereditary Optic Neuropathy 
Gensight (Euronext: SIGHT)
26 May 2016
Press Release
MIN-101 Meets Primary & Secondary Endpoints In Phase IIB Trial 
Minerva Neurosciences (NASDAQ: NERV)
26 May 2016
Press Release
Minerva Neurosciences Announces Positive Results in Phase IIA Trial of MIN-117 in Major Depressive Disorder 
Minerva Neurosciences (NASDAQ: NERV)
22 May 2016
Press Release
Acutus Medical Completes $75 Million Series C Financing 
Acutus Medical
18 May 2016
Press Release
Novel Ultrasound-based Imaging and Global Dipole Density Mapping: Feasibility in Persistent Atrial Fibrillation Heart Rhythm Society May 2016 Poster PO03 
Acutus Medical
30 Mar 2016
In The News
Nasdaq Globe Newswire
Palladio Biosciences, Inc. Named “Best in Show” at Mid-Atlantic Bio Angels 1st Pitch Philadelphia Event 
29 Mar 2016
Press Release
Bristol-Myers Squibb to Acquire Padlock Therapeutics, Inc. 
Padlock Therapeutics - Acquired by BMS
29 Mar 2016
Press Release
Gadeta Closes EUR 7 Million Series A Financing to Advance Novel Cancer Immunotherapies to the Clinic 
Gadeta - Acquired by Century Therapeutics (NASDAQ:IPSC)
11 Mar 2016
Press Release
Minerva Neurosciences Announces Positive Top Line Results From Phase Ib Clinical Trial in Major Depressive Disorder With MIN-202 
Minerva Neurosciences (NASDAQ: NERV)
08 Mar 2016
Press Release
Antibody Firm Capella raises $15.5M for Novel Targets, Good Biology 
Capella - Centessa Therapeutics (NASDAQ:CNTA)
08 Mar 2016
Press Release
Capella Bioscience Completes Series A Financing of £11 million ($15.5 million) to Progress Antibody Pipeline 
Capella - Centessa Therapeutics (NASDAQ:CNTA)
07 Mar 2016
In The News
FierceBiotech
Capella Bio Harnesses a Virtual Global Team to a Targeted Antibody R&D Strategy 
07 Mar 2016
Press Release
Molecular Partners Reveals Programs in Immuno-Oncology 
Molecular Partners (S​wiss​: MOLN.SW)
29 Feb 2016
Press Release
Egalet Announces FDA Acceptance of New Drug Application for ARYMO™ ER (Morphine Sulfate) Extended-Release Tablets 
Egalet (NASDAQ:EGLT)
29 Feb 2016
Press Release
GenSight Biologics Enrolls First Patient in Pivotal Phase III Program of GS010 in Leber’s Hereditary Optic Neuropathy 
Gensight (Euronext: SIGHT)
14 Feb 2016
In The News
Sunday Times
University spin-outs demand a better deal 
08 Feb 2016
In The News
BioCentury
Asset renaissance: How Medicxi increases Phase II success with less capital (subscription required) 
02 Feb 2016
In The News
FT
J&J and GSK join Medicxi’s European life sciences push 
02 Feb 2016
In The News
BioWorld
Zeroing in on early stage European research, Index launches $250M fund (subscription required) 
02 Feb 2016
In The News
Bloomberg
Index Ventures Spins Off Biotech Investment Arm Into New Firm 
02 Feb 2016
In The News
Reuters
Guess What This Early Skype Investor Is Betting on Now 
02 Feb 2016
In The News
SCRIP
INTERVIEW: Why Medicxi Spun Itself Out Of Index (subscription required) 
02 Feb 2016
In The News
Bilan
Medicxi, le spin-off à un milliard d’Index Ventures 
02 Feb 2016
Press Release
Versartis Reports Confirmatory Top-Line Two-Year Data from Ongoing Extension Study of Somavaratan in GHD Children 
Versartis (NASDAQ: VSAR)
02 Feb 2016
Blog
Who are the Medicxi founding team?
02 Feb 2016
Press Release
Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing of a €210m Fund including GSK and Johnson & Johnson Innovation
02 Feb 2016
Blog
The Formation of Medicxi
01 Feb 2016
In The News
FierceBiotech
Backed by J&J and Glaxo, veteran VC group splits from Index, unveils $227M fund 
01 Feb 2016
Press Release
Minerva Neurosciences Announces Top Line Data From MIN-202 Phase I Clinical Study in Japanese Patients 
Minerva Neurosciences (NASDAQ: NERV)
11 Jan 2016
Press Release
Minerva Neurosciences Announces Favorable Top Line Results From MIN-202 Phase 2A Clinical Trial in Insomnia Disorder 
Minerva Neurosciences (NASDAQ: NERV)
08 Jan 2016
Press Release
Aegerion Pharmaceuticals to Present at the 34th Annual J.P. Morgan 
Aegerion (NASDAQ: AEGR) - Novelion
04 Jan 2016
Press Release
Addex’ Dipraglurant Receives Orphan Drug Designation from the FDA for Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease 
Addex (Swiss ADXN.SW)
21 Dec 2015
Press Release
Genmab Achieves $3 Million Milestone in DuoBody Platform Collaboration with Janssen 
Genmab (Copenhagen: GEN.CO)